BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 12, 2001
View Archived Issues
Licensing opportunity from NIH: novel posttranscriptional regulatory elements
Read More
Licensing opportunity from NIH: acridine derivative for overcoming MDR
Read More
Gilead reports product and pipeline highlights for 2000
Read More
Nicotine replacement therapy business of Aventis acquired by Pharmacia
Read More
Alza acquires Flexeril product and trademark from Merck & Co.
Read More
ARGENT technology demonstrates potential in prostate cancer
Read More
Medarex and Seattle Genetics to jointly develop human antibody therapeutics
Read More
NCX-530 is less toxic than indomethacin to the intestine according to rat studies
Read More
Highly potent HIV protease inhibitors from Tibotec may prevent class-wide crossresistance
Read More
Magainin and Ludwig Institute further their gene/protein-based alliance
Read More
Inhibitor of HIV-1 Rev function acts on receptor-mediated export
Read More
Kinetic and clinical data presented in Chicago support further development of DAPD
Read More
Approvable letter issued by FDA for GlaxoSmithKline's Avandia in combination with insulin
Read More
LDP-02 enters phase II in Canada for ulcerative colitis
Read More
Next-generation NNRTI advances to clinical testing in HIV-infected subjects
Read More
Second-generation HIV protease inhibitors retain activity against highly resistant strains
Read More
KS Biomedix's KSB-301 enters phase II for osteoarthritis
Read More
Promising preclinical data reported for Isotechnika immunosuppressant in type 1 diabetes
Read More
First oral chemotherapy for treatment of metastatic colorectal cancer approved in Europe
Read More
Antisense modulators of integrin beta3 expression
Read More
Isis designs antisense oligonucleotides that modulate the expression of G-proteins
Read More
Cationic peptides with antibacterial activity described by Canadian university
Read More
Novel series for diabetes and related disorders emerges from Tularik-JT collaboration
Read More
Panacos and collaborators discuss preclinical profile of anti-HIV candidate
Read More
Aventis presents new antibacterial agents derived from moenomycin A
Read More
European patent issued to Pfizer for new opioid receptor antagonists
Read More
Heterocyclic inhibitors of tyrosine kinase-mediated signal transduction
Read More
Kissei and Purdue Pharma terminate licensing agreement for mitiglinide
Read More